Stay updated on Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe update adds and refines the study overview, design details, and eligibility criteria for the Fenebrutinib RMS trial, and expands the list of participating sites across the United States and internationally, clarifying the study's scope and operational footprint.SummaryDifference1%

- Check15 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This represents a new page revision without changes to the study information.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous version, signaling a minor update to the page template.SummaryDifference0.0%

- Check43 days agoChange DetectedThe bottom of the page now shows Revision: v3.5.2, replacing the previous v3.5.0. This appears to be a minor version update with no impact on study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe Veneto, Italy site entry changed from Padua (35128) to Padova (35128) in the location list.SummaryDifference0.0%

- Check65 days agoChange DetectedTwo Italian study locations were updated from Napoli, Campania, Italy to Naples, Campania, Italy (postal codes 80131 and 80138); revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.